This announcement is a separate document:
佐力药业:国金证券股份有限公司关于浙江佐力药业股份有限公司2024年度持续督导培训情况的报告
Zuoli Pharmaceutical: Report by Guojin Securities Co., Ltd. on the 2024 continuous supervision and training situation of Zhejiang Zuoli Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.